Clinical Trial Update: Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide [Phase 2]

View source ↗

Summary

Phase 2 trial assessing PC-515 as a vaginal microbicide reports safety, acceptability, and preliminary effectiveness data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia Infection
• Genital Herpes
• Gonorrhea
• HIV Infection
• Syphilis
• Trichomoniasis

Drugs mentioned

• PC-515

Snippet

Sponsor: Population Council | Conditions: HIV Infections, Chlamydia Trachomatis | Phase 2 | Status: COMPLETED